Categories: Health Care

Curatio Healthcare Gears up for Next Phase of Growth, Eyes Global Markets Aims to Create Wealth for its Stakeholders


Mumbai, 19 Mar, 2015: 
Curatio Healthcare, one of the fastest growing specialized dermatology companies in India, announced its plans for an aggressive growth path, with an eye on global markets and offering the opportunity to enhance wealth creation for its employees. The company also announced the appointment of P. V. Sankar Dass as the Chief Operating Officer. This comes on the heels of the company having secured INR 100 crore in Series B funding from Sequoia Capital to further accelerate the company’s growth.

Founded in 2005, Curatio Healthcare offers innovative solutions to plug the therapy gaps in the areas of cosmetic and medical dermatology. The company, with a network of over 300 medical representatives across India, has a wide portfolio of 40 SKUs catering to pigmentary disorders, emollients and protectives, haircare and acne therapy.

Speaking on the strategy for growth, GK Ramani, Managing Director said “ The focus will be on overseas expansion, strategic acquisitions and licensing opportunities. Our way of growing business is to provide value to our customers, like meeting their specific hitherto unmet needs or by the uniqueness of a product utility. We are ready for the next phase of growth and we look forward to working closely with Sequoia to take Curatio to the next level.”

Commenting on the developments, Krishna Ramanathan, Founder Fulcrum Venture India said, “In the last two years, Curatio has established Pan India operations, enhancing its team of Medical Representatives and offered SKUs thereby building a strong brand equity with Dermatologists . Through our strengths in product development, Curatio has grown at a brisk pace, faster than most of our peers and above the industry average. And I derive great satisfaction from the fact that Curatio has created wealth for not just its promoters and angel investors but also for its employees and the management remains committed to expand on the stock option scheme in the years to come.”

Mr. Sankar Dass, COO Curatio added, “Curatio has grown steadily in the last few years and has successfully created a mark in the Indian dermatology market. I personally share the philosophy of wealth creation for employees, and am confident of having inherited a motivated field force. I am proud to be a part of t he company that is well positioned to achieve greater heights through growth and innovation.

Abhay Pandey, Managing Director, Sequoia Capital India Advisors will be joining the board.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

2 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

4 days ago